Collectively, our findings support a CPSF6-APA-iron homeostasis axis as an important co-/post- transcriptional regulatory mechanism in erythropoiesis, and implicate its dysregulation in the pathogenesis of PV, offering novel molecular targets for therapeutic intervention in myeloproliferative neoplasms. Here, ENPEP is linked to myeloproliferative disorder.